American International Group’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5,096
Closed -$45 3309
2021
Q1
$45 Buy
5,096
+14
+0.3% +$154 ﹤0.01% 3008
2020
Q4
$52 Sell
5,082
-146
-3% -$1.6K ﹤0.01% 2958
2020
Q3
$47K Sell
5,228
-120
-2% -$951 ﹤0.01% 2905
2020
Q2
$38K Buy
5,348
+4,335
+428% +$46K ﹤0.01% 2966
2020
Q1
$10K Sell
1,013
-39
-4% -$503 ﹤0.01% 3008
2019
Q4
$14K Buy
+1,052
New +$12.8K ﹤0.01% 3040

Other funds holding GRTX

American International Group's GRTX Position: Q2 2021 in Review

American International Group sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2021, closing a stake of 5,096 shares — an estimated $45 sold.

American International Group first reported a position in GRTX in Q4 2019 and held it in 6 quarters. The position peaked at $47K in Q3 2020. 47 funds tracked by Wall St. Rank hold GRTX as of Q2 2021.

  • American International Group reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 5,096 Galera Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $45.
  • American International Group first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
  • American International Group's Galera Therapeutics, Inc. Common Stock position peaked at $47K in Q3 2020.
  • 47 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.